Document Classification

Section Type: RESULTS

Text: Patients assigned sequential BCG and electromotive mitomycin also had lower recurrence (41. 9 % [32. 7-51. 5] vs 57. 9 % [48. 7-67. 5] ; difference between groups 16. 0 % [2. 7-29. 3], log-rank p = 0. 0012) ; progression (9. 3 % [3. 8-14. 8] vs 21. 9 % [17. 9-25. 9] ; difference between groups 12. 6 % [3. 0-22. 2], log-rank p = 0. 004) ; overall mortality (21. 5 % [13. 5-29. 5] vs 32. 4 % [23. 4-41. 4], difference between groups 10. 9 % [0. 6-21. 2], log-rank p = 0. 045) ; and disease-specific mortality (5. 6 % [1. 2-10. 0] vs 16. 2 % [6. 1-23. 3], difference between groups 10. 6 % [2. 5-18. 7], log-rank p = 0. 01).